$WAL

Kennedy Barbara sold (to issuer) $21K of WAL

Kennedy Barbara (Chief Human Resources Officer) sold (to issuer) 257 shares of WESTERN ALLIANCE BANCORPORATION (WAL) at $81.81 across 3 trades on 2026-06-15.

Original reporting
SEC EDGAR · Kennedy Barbara
Published Jun 17, 2026, 9:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 17, 2026, 9:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$WAL
Neutral
high confidence
Mentioned
$WAL
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$WALNeutralLow
01

Why it matters

The newest disclosed fact is the CHRO’s sale to the issuer of 257 shares at $81.81 on 2026-06-15; no other company-specific news is provided.

02

Market read

Traders may note the insider sale, but the filing lacks any fundamental catalyst and the transaction size is modest.

03

What to watch

The transaction is a sale to the issuer (often buyback-related mechanics), and the dollar size is small versus typical institutional flows, limiting tradable signal.

Relevance 3/10Novelty 4/10Timing: Filed 2026-06-17; transaction dated 2026-06-15.

Background

The article is an SEC Form 4 insider transaction disclosure for Western Alliance Bancorporation (WAL).

Company-level read

Ticker impact

$WALNeutralHigh confidence
Context

Western Alliance Bancorporation disclosed an insider sale to the issuer: 257 shares sold at $81.81 on 2026-06-15 by its CHRO, Kennedy Barbara.

Expected impact

Likely minimal immediate price impact; any effect would be sentiment-driven and short-lived.

Evidence & confidence

The filing is a small insider transaction ($21.0k) with no 10b5-1 plan and no accompanying operational/regulatory catalyst in the text.

Market effects

No clear sector read-through; this is an isolated insider transaction disclosure.

None indicated; no broader banking system or regional catalyst mentioned.

None indicated; filing contains no macro or cross-border development.

Counterpoint

Absence of a 10b5-1 plan could be interpreted as less “scheduled,” so some traders may view it as marginally more bearish than typical routine sales.

Key entities

  • WESTERN ALLIANCE BANCORPORATION

    Subject of the Form 4 insider transaction disclosure.

  • Kennedy Barbara

    Chief Human Resources Officer who sold shares to the issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WALMed

Stephens cuts Western Alliance stock price target on NII outlook

Stephens reduced its price target on Western Alliance Bancorporation (WAL) to $88 from $94, citing lower net interest income expectations. The bank's Q3 earnings per share missed estimates at $2.32, but its credit profile improved. WAL returned $212.5M to shareholders over the past year and expects $60M in Q4 buybacks. Stephens also lowered its 2027 and 2028 EPS estimates. Despite a Q3 2026 earnings beat, WAL stock trades below its 52-week high.

$WALHighAI 8/10

Western Alliance Bancorp (WAL) (Q3 2026) Earnings Call Highlights: Deposit Optimization

Western Alliance Bancorp (WAL) reported Q3 2026 earnings with nonaccrual loans declining 14% and deposit costs reduced by $14 million. PPNR grew 6% YoY to $419 million, and EPS increased 7.5% to $2.45. However, total deposits declined $119 million, and loan growth outlook was revised lower. Net interest income growth outlook was reduced to 11%-12%. Share repurchases totaled $92 million. Management discussed deposit optimization, loan growth strategy, and expense outlook.

$WALMed

Western Alliance Bancorp (WAL) Reports Solid Q3 2026 Results wit

Western Alliance Bancorp (WAL) reported Q3 2026 results with a 6% YoY increase in pre-provision net revenue to $419M and a 7.5% rise in EPS to $2.45. The bank improved asset quality, reduced nonaccrual loans by 14%, and repurchased $92M in shares. WAL's P/S ratio is 2.12x, below its historical median of 3.9x, indicating cautious market growth expectations. The company's GF Score is 88/100, reflecting strong growth and profitability but weak financial strength.

$WALHighAI 8/10

Western Alliance Bancorp (WAL) (Q3 2026) Earnings Call Highlight

Western Alliance Bancorp (WAL) reported Q3 2026 earnings with net revenue up $76M YoY. Net interest income rose 8% YoY to $808M, while noninterest income increased 10% YoY to $207M. Net income grew 6% YoY to $277M, with EPS up 7.5% to $2.45. Deposit costs decreased $14M QoQ, and nonaccrual loans fell 14% QoQ. Loan growth guidance was revised lower by $1B, and deposit growth outlook was reduced to $3.5B-$4B. Share repurchases totaled $92.1M in Q3.

$WALHighAI 8/10

Western Alliance (WAL) Q3 2026 Earnings Call Transcript

Western Alliance (WAL) reported Q3 2026 earnings with PPNR up 6% YoY to $419M, EPS up 7.5% to $2.45, and net income up 6% to $277M. The company completed $4.5B in deposit optimization, reducing costs, and repurchased $92M in shares. HFI loans grew 5.4% QoQ, and ROA increased to 15.5%. Management expects further deposit cost reductions in Q4 and remains on track to meet medium-term goals.

$WALMedAI 8/10

Western Alliance Bancorporation Q3 Earnings Call Highlights

Western Alliance Bancorporation (WAL) reported Q3 earnings with deposit optimization driving margin expansion. Deposit costs fell $14M, contributing to a 10-basis-point increase in adjusted net interest margin. Total deposits were $81.8B, with commercial banking deposits rising to 34% of total. Earnings per share increased 7.5% YoY to $2.45. Management expects deposit costs to decline further but anticipates a seasonal NIM headwind.